Onset and duration of protection against exercise-induced bronchoconstriction by a single oral dose of montelukast.

[1]  J. Kelso.  Inflammatory Basis of Exercise-Induced Bronchoconstriction , 2006, Pediatrics.

[2]  W. Henderson,et al.  Inflammatory basis of exercise-induced bronchoconstriction. , 2005, American journal of respiratory and critical care medicine.

[3]  J. Lötvall,et al.  Past, present and future--beta2-adrenoceptor agonists in asthma management. , 2005, Respiratory medicine.

[4]  S. Anderson,et al.  Long-Acting β2-Adrenoceptor Agonists and Exercise-Induced Asthma , 2004 .

[5]  H. Selvadurai,et al.  Management of Exercise-Induced Bronchospasm in Children , 2004 .

[6]  H. Selvadurai,et al.  Management of exercise-induced bronchospasm in children: the role of leukotriene antagonists. , 2004, Treatments in respiratory medicine.

[7]  S. Anderson,et al.  Long-acting beta 2-adrenoceptor agonists and exercise-induced asthma: lessons to guide us in the future. , 2004, Paediatric drugs.

[8]  S. Anderson.  Single-Dose Agents in the Prevention of Exercise-Induced Asthma , 2004, Treatments in respiratory medicine.

[9]  B. Rowe,et al.  Mast-cell stabilising agents to prevent exercise-induced bronchoconstriction. , 2003, The Cochrane database of systematic reviews.

[10]  C. Camargo,et al.  A randomized controlled trial of intravenous montelukast in acute asthma. , 2003, American journal of respiratory and critical care medicine.

[11]  L. Mastalerz,et al.  Protection against exercise‐induced bronchoconstriction by montelukast in aspirin‐sensitive and aspirin‐tolerant patients with asthma , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[12]  T. Reiss,et al.  Clinical pharmacology of montelukast , 2001 .

[13]  T. Reiss,et al.  Clinical efficacy of montelukast in adults and children , 2001 .

[14]  N. Santanello,et al.  Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years. , 2001, Pediatrics.

[15]  J. Price,et al.  Choices of therapy for exercise‐induced asthma in children , 2001, Allergy.

[16]  E. R. Mcfadden,et al.  Comparative effects of long-acting beta2-agonists, leukotriene receptor antagonists, and a 5-lipoxygenase inhibitor on exercise-induced asthma. , 2000, The Journal of allergy and clinical immunology.

[17]  K. Kelly,et al.  Nedocromil sodium versus sodium cromoglycate for preventing exercise-induced bronchoconstriction , 2000 .

[18]  E. Bronsky,et al.  Oral Montelukast Compared with Inhaled Salmeterol To Prevent Exercise-Induced Bronchoconstriction , 2000, Annals of Internal Medicine.

[19]  K. Kelly,et al.  Nedocromil sodium versus cromoglycate for the pre-treatment of exercise induced bronchoconstriction in asthma. , 2000, The Cochrane database of systematic reviews.

[20]  K. Kelly,et al.  Nedocromil sodium vs. sodium cromoglycate for preventing exercise-induced bronchoconstriction in asthmatics. , 2000, The Cochrane database of systematic reviews.

[21]  A. Chuchalin,et al.  Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction. Montelukast/Salmeterol Exercise Study Group. , 1999, The Journal of allergy and clinical immunology.

[22]  L. Boulet,et al.  Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial. , 1999, The European respiratory journal.

[23]  C. Bonuccelli,et al.  The leukotriene D4-receptor antagonist zafirlukast attenuates exercise-induced bronchoconstriction in children. , 1999, The Journal of pediatrics.

[24]  K. McDowell.  Montelukast, A Leukotriene-Receptor Antagonist, for the Treatment of Mild Asthma and Exercise-Induced Bronchoconstriction , 1999 .

[25]  K. Beck,et al.  Control of airway function during and after exercise in asthmatics. , 1999, Medicine and science in sports and exercise.

[26]  J. Kemp,et al.  Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma. , 1998, The Journal of pediatrics.

[27]  H. Magnussen,et al.  Effects of a 5-lipoxygenase inhibitor, ABT-761, on exercise-induced bronchoconstriction and urinary LTE4 in asthmatic patients. , 1998, The European respiratory journal.

[28]  T. Reiss,et al.  Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist. , 1997, Thorax.

[29]  J. Kemp,et al.  Dose‐related protection of exercise bronchoconstriction by montelukast, a cysteinyl leukotriene–receptor antagonist, at the end of a once‐daily dosing interval , 1997, Clinical pharmacology and therapeutics.

[30]  P. O'Byrne.  Exercise‐induced Bronchoconstriction: Elucidating the Roles of Leukotrienes and Prostaglandins , 1997, Pharmacotherapy.

[31]  J. Weiler.  Exercise-induced asthma: a practical guide to definitions, diagnosis, prevalence, and treatment. , 1996, Allergy and asthma proceedings.

[32]  E. Bleecker,et al.  Inhibition of exercise-induced bronchospasm by zileuton: a 5-lipoxygenase inhibitor. , 1996, American journal of respiratory and critical care medicine.

[33]  E. Israel.  Moderating the inflammation of asthma: inhibiting the production or action of products of the 5-lipoxygenase pathway. , 1994, Annals of allergy.

[34]  A. Nakai,et al.  Urinary leukotriene E4 after exercise challenge in children with asthma. , 1992, The Journal of allergy and clinical immunology.

[35]  P. O'Byrne,et al.  Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist. , 1990, The New England journal of medicine.

[36]  Pathogenetic mechanisms of exercise induced asthma and the refractory period. , 1988, Acta paediatrica Japonica : Overseas edition.

[37]  J. Henriksen.  Exercise‐Induced Bronchoconstriction , 1986, Allergy.

[38]  A. Bundgaard,et al.  EXERCISE-INDUCED ASTHMA , 1978 .

[39]  E. R. Mcfadden,et al.  Exercise-induced asthma. , 1994, The New England journal of medicine.

[40]  S. Godfrey,et al.  Demonstration by placebo response in asthma by means of exercise testing. , 1973, Journal of psychosomatic research.